人类MX2是一种干扰素诱导的HIV-1感染后进入抑制剂
Caroline Goujon1, Olivier Moncorgé, Hélène Bauby
1Department of Infectious Diseases, King's College London, London SE1 9RT, UK.
Nature
|September 20, 2013
概括
异型病毒抗性2 (MX2) 蛋白质通过阻断病毒DNA集成,强烈抑制人体免疫缺陷病毒1型 (HIV-1) 感染. 这种干扰素刺激的因子代表了艾滋病毒/艾滋病的潜在新治疗点.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 细胞生物学 细胞生物学
背景情况:
- 动物细胞具有天生的免疫力,可以限制病毒的复制.
- 人类免疫缺陷病毒1型 (HIV-1) 被各种限制因素和干扰素刺激基因抑制.
- 抗菌病毒抗性2 (MX2) 是一种具有抗病毒性质的干扰素诱导蛋白质.
研究的目的:
- 识别和描述抑制HIV-1复制的新型宿主因素.
- 定义MX2作为干扰素介导的抗HIV-1活性的效应因子的作用.
- 阐明MX2限制HIV-1感染的机制.
主要方法:
- 使用了子宫外表达和基因沉默实验.
- 评估了HIV-1菌株和其他逆转录病毒的抑制.
- 研究了病毒Gag蛋白的Capsid区域在MX2易感性中的作用.
- 分析了病毒DNA复制的进入后步骤,包括核积累和染色体融合.
主要成果:
- MX2被确定为HIV-1感染的强有力的抑制剂,对所有测试的菌株有效.
- MX2通过向进入后的晚期阶段来抑制感染,从而抑制病毒DNA的核积累和集成.
- 对MX2的敏感性是由HIV-1 Gag蛋白的Capsid区域决定的.
- 与MX1.1不同的是,MX2对猿类免疫缺陷病毒和其他逆转录病毒的活性较低或不存在,并且对流感病毒无效.
结论:
- MX2是一个关键的,细胞自主限制因子,对抗HIV-1感染.
- MX2作为1型干扰素诱导的HIV-1抗性的关键作用因子.
- 针对MX2可能为艾滋病毒/艾滋病治疗提供一种新的治疗策略.
相关概念视频
Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
Cytomegalovirus Disease
Cytomegalovirus (CMV) disease is caused by human cytomegalovirus, a double-stranded DNA virus of the Herpesviridae family. While primary CMV infection is often asymptomatic in immunocompetent individuals, the virus can cause severe disease in neonates and immunocompromised patients. CMV is the most common cause of congenital viral infection in the United States, and a major pathogen in solid organ and hematopoietic stem cell transplant recipients.CMV is transmitted via bodily fluids, sexual...
Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
Immune Response Against Viral Pathogens
The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Viruses with RNA Genomes
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
Antigens Involved in Adaptive Immunity
An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.


